Controlled Drug Delivery : (Record no. 67264)

MARC details
000 -LEADER
fixed length control field 08576nam a22005053i 4500
001 - CONTROL NUMBER
control field EBC1887729
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20191126082707.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 191125s2014 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781908818676
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9781907568459
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC1887729
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL1887729
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr11000075
035 ## - SYSTEM CONTROL NUMBER
System control number (CaONFJC)MIL679159
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)898421820
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RS199.5 -- .C668 2015eb
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.6
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mateescu, M. A.
9 (RLIN) 14425
245 10 - TITLE STATEMENT
Title Controlled Drug Delivery :
Remainder of title The Role of Self-Assembling Multi-Task Excipients.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Kent :
Name of producer, publisher, distributor, manufacturer Elsevier Science & Technology,
Date of production, publication, distribution, manufacture, or copyright notice 2014.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©2015.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (269 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Woodhead Publishing Series in Biomedicine Ser.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Front Cover -- Controlled Drug Delivery -- Copyright Page -- Contents -- List of figures -- List of tables -- Biography for book -- 1 The concept of self-assembling and the interactions involved -- 1.1 The concept of self-assembling -- 1.1.1 The concept of self-assembling by association/interaction processes -- 1.2 The nature of forces and types of interactions involved in self-assembly of macromolecules -- 1.3 Hydrogels and their role in drug conception and development -- 1.3.1 Organogels and micelles for drug delivery -- 1.4 Self-assembling phenomena in solid dosage forms -- 1.4.1 Hydrogen association and flexibility of chains -- 1.4.2 Ionically stabilized excipients -- 1.4.2.1 Two-speed self-assembled monolithic devices -- 1.4.3 Hydrophobic stabilization of excipients and drug release mechanisms -- 1.4.3.1 The concept of self-assembling by inclusion processes -- 1.4.3.2 Inclusion complexes of starch with fatty bioactive agents -- 1.4.3.3 Inclusion complexes and hydrophobic assembly of starch excipients -- 1.5 Conclusions -- References -- 2 Starch and derivatives as pharmaceutical excipients -- 2.1 General aspects -- 2.2 Structural considerations -- 2.3 Self-assembling in physically modified starches -- 2.3.1 Pregelatinized starch -- 2.3.2 Multifunctional excipient: binder-filler and binder-disintegrant -- 2.3.3 Extruded starch -- 2.3.4 Soft starch capsules -- 2.3.5 Hard capsules -- 2.3.6 Starch films as functional coatings -- 2.3.7 Starch microspheres and nanospheres in drug delivery -- 2.3.8 Starch complexes -- 2.3.9 Conclusions -- 2.4 Chemically modified starches and their self-assembling -- 2.4.1 Self-assembling in cross-linked starches -- 2.4.2 Starch ethers -- 2.4.3 Ionic starches and their self-assembling features -- 2.4.3.1 CMS as pH-responsive excipient -- 2.4.3.2 Cationic starch -- 2.4.4 Conclusions -- References.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 3 Chitosan and its derivatives as self-assembled systems for drug delivery -- Abbreviations -- 3.1 Introduction -- 3.2 Unmodified chitosan-self-assembled thermogels -- 3.2.1 Mechanism of chitosan thermogelation -- 3.2.2 Chitosan thermogels -- 3.3 Amphiphilic chitosan derivatives -- 3.3.1 Alkylated chitosan -- 3.3.2 Acylated chitosan -- 3.3.2.1 Acylated chitosan -- 3.3.2.2 Acylated chitosan oligosaccharides -- 3.3.3 Cholesterol-modified chitosan -- 3.3.4 Cholic and deoxycholic acid-modified chitosan -- 3.3.5 5β-Cholanic acid-modified chitosan -- 3.3.6 Phthaloylchitosan and other hydrophobically modified chitosans -- 3.3.7 Hydrophobic drug-grafted chitosan -- 3.4 Amphiphilic/amphoteric chitosan derivatives -- 3.4.1 Hydrophobically modified carboxylated chitosan -- 3.4.1.1 Alkyl-modified carboxylated chitosan -- 3.4.1.2 Acyl-modified carboxylated chitosan -- 3.4.1.3 Cholesterol-modified carboxylated chitosan -- 3.4.1.4 Deoxycholic acid-modified carboxylated chitosan -- 3.4.2 Hydrophobically modified sulfated chitosan -- 3.5 Conclusion -- References -- 4 Chitosan-based polyelectrolyte complexes as pharmaceutical excipients -- Abbreviations -- 4.1 Introduction to chitosan-based polyelectrolyte complexes -- 4.1.1 Overview of chitosan-based polyelectrolyte complexes -- 4.1.2 Chitosan-based PECs in drug delivery -- 4.2 Chitosan-chondroitin sulfate PEC -- 4.3 Chitosan-carboxymethyl starch PEC -- 4.4 Chitosan-dextran sulfate PEC -- 4.5 Chitosan-pectin PEC -- 4.6 Chitosan-alginate PEC -- 4.6.1 Formulation of active agents with chitosan-alginate PEC -- 4.6.2 Chitosan-alginate beads -- 4.6.2.1 Small molecules -- 4.6.2.2 Proteins -- 4.6.2.3 Other active agents -- 4.6.3 Chitosan-alginate microspheres -- 4.6.4 Chitosan-alginate microcapsules -- 4.6.4.1 Small molecules -- 4.6.4.2 Proteins -- 4.6.5 Chitosan-alginate microparticles.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 4.6.6 Chitosan-alginate nanoparticles and other forms -- 4.7 Chitosan complexed with other polysaccharides -- 4.8 Conclusion -- References -- 5 Self-assembling in natural, synthetic, and hybrid materials with applications in controlled drug delivery -- 5.1 General considerations -- 5.2 Natural polysaccharides and their derivatives used in controlled drug release -- 5.3 Self-assembling of synthetic polymers -- 5.3.1 Block copolymers as multitasking excipients for biomedical applications -- 5.3.1.1 Hydrogels -- 5.3.1.2 Thermoresponsive gels -- 5.3.1.3 Nanogels -- 5.3.1.4 Nanoparticles -- 5.3.1.5 Liposomes -- 5.3.2 Layer-by-layer self-assembled structures for drug delivery -- 5.4 Hybrid materials obtained by self-assembling -- 5.5 Conclusions -- References -- 6 Protein-protein associative interactions and their involvement in bioformulations -- 6.1 Introduction -- 6.2 Generalities on proteins, their roles, and their possible use as excipients -- 6.3 Albumin microspheres and nanoparticles for drug delivery -- 6.4 Self-assembling processes involving albumin and bioactive agents -- 6.5 Collagen: generalities and utilizations as material for biopharmaceutical applications -- 6.5.1 The collagen structure -- 6.5.1.1 Collagen cross-linking -- 6.5.2 Collagen-based biomaterials -- 6.5.3 CPMs and recognition self-assembling -- 6.6 Protein excipients for solid dosage forms -- 6.7 Pharmaceutical solid, oral, high-loaded, and gastro-resistant dosage forms of therapeutic enzymes -- 6.8 Gastro-resistant excipient-free pharmaceutical forms of therapeutic enzymes -- 6.9 Conclusion -- References -- Index.
520 ## - SUMMARY, ETC.
Summary, etc. In complex macromolecules, minor modifications can generate major changes, due to self-assembling capacities of macromolecular or supramolecular networks. Controlled Drug Delivery highlights how the multifunctionality of several materials can be achieved and valorized for pharmaceutical and biopharmaceutical applications. Topics covered in this comprehensive book include: the concept of self-assembling; starch and derivatives as pharmaceutical excipients; and chitosan and derivatives as biomaterials and as pharmaceutical excipients. Later chapters discuss polyelectrolyte complexes as excipients for oral administration; and natural semi-synthetic and synthetic materials. Closing chapters cover protein-protein associative interactions and their involvement in bioformulations; self-assembling materials, implants and xenografts; and provide conclusions and perspectives. Offers novel perspectives of a new concept: how minor alterations can induce major self-stabilization by cumulative forces exerted at short and long distances Gives guidance on how to approach modifications of biopolymers for drug delivery systems and materials for implants Describes structure-properties relationships in proposed excipients, drug delivery systems and biomedical materials.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2019. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug delivery systems.;Excipients.;Self-organizing systems.
9 (RLIN) 14426
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
9 (RLIN) 14427
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ispas-Szabo, P.
9 (RLIN) 14428
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Assaad, E.
9 (RLIN) 14429
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Mateescu, M. A.
Title Controlled Drug Delivery : The Role of Self-Assembling Multi-Task Excipients
Place, publisher, and date of publication Kent : Elsevier Science & Technology,c2014
International Standard Book Number 9781907568459
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Woodhead Publishing Series in Biomedicine Ser.
9 (RLIN) 14430
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/thebc/detail.action?docID=1887729">https://ebookcentral.proquest.com/lib/thebc/detail.action?docID=1887729</a>
Public note Click to View
887 ## - NON-MARC INFORMATION FIELD
Content of non-MARC field EBK
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Ebrary
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Barcode Date last seen Price effective from Koha item type
        Afghanistan Afghanistan 26/11/2019   EBKAF-N0001092 26/11/2019 26/11/2019 Ebrary
        Algeria Algeria           Ebrary
        Cyprus Cyprus           Ebrary
        Egypt Egypt           Ebrary
        Libya Libya           Ebrary
        Morocco Morocco           Ebrary
        Nepal Nepal 26/11/2019   EBKNP-N0001092 26/11/2019 26/11/2019 Ebrary
        Sudan Sudan           Ebrary
        Tunisia Tunisia           Ebrary